BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11361221)

  • 1. Therapeutic effect of anti-Fas antibody on a collagen induced arthritis model.
    Ogawa Y; Kuwahara H; Kimura T; Tani Y; Yonehara S; Shiraishi A; Ohtsuki M
    J Rheumatol; 2001 May; 28(5):950-5. PubMed ID: 11361221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells.
    Fan K; Dai J; Wang H; Wei H; Cao Z; Hou S; Qian W; Wang H; Li B; Zhao J; Xu H; Yang C; Guo Y
    Arthritis Rheum; 2008 Jul; 58(7):2041-52. PubMed ID: 18576331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice.
    Fujisawa K; Asahara H; Okamoto K; Aono H; Hasunuma T; Kobata T; Iwakura Y; Yonehara S; Sumida T; Nishioka K
    J Clin Invest; 1996 Jul; 98(2):271-8. PubMed ID: 8755634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antirheumatic effects of humanized anti-Fas monoclonal antibody in human rheumatoid arthritis/SCID mouse chimera.
    Matsuno H; Yudoh K; Nakazawa F; Sawai T; Uzuki M; Nishioka K; Yonehara S; Nakayama J; Ohtsuki M; Kimura T
    J Rheumatol; 2002 Aug; 29(8):1609-14. PubMed ID: 12180717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of osteoclastogenesis in rheumatoid arthritis by induction of apoptosis in activated CD4+ T cells.
    Ogawa Y; Ohtsuki M; Uzuki M; Sawai T; Onozawa Y; Nakayama J; Yonemura A; Kimura T; Matsuno H
    Arthritis Rheum; 2003 Dec; 48(12):3350-8. PubMed ID: 14673986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra.
    Joosten LA; Helsen MM; van de Loo FA; van den Berg WB
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S110-22. PubMed ID: 18240201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 involvement in experimental collagen-induced arthritis (CIA).
    Nedvetzki S; Walmsley M; Alpert E; Williams RO; Feldmann M; Naor D
    J Autoimmun; 1999 Aug; 13(1):39-47. PubMed ID: 10441166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
    Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
    Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell receptor V beta 8 has no significant suppressive effect on collagen-induced arthritis.
    Matsuno H; Kadowaki KM; Suzuki H; Ochiai H; Tsuji H
    Int J Tissue React; 1993; 15(1):1-9. PubMed ID: 8282479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential withdrawal of rheumatoid synovium by the induction of apoptosis using a novel in vivo model of rheumatoid arthritis.
    Sakai K; Matsuno H; Morita I; Nezuka T; Tsuji H; Shirai T; Yonehara S; Hasunuma T; Nishioka K
    Arthritis Rheum; 1998 Jul; 41(7):1251-7. PubMed ID: 9663483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced efficacy of regulatory T cell transfer against increasing resistance, by elevated Foxp3 expression induced in arthritic murine hosts.
    Ohata J; Miura T; Johnson TA; Hori S; Ziegler SF; Kohsaka H
    Arthritis Rheum; 2007 Sep; 56(9):2947-56. PubMed ID: 17763426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient promotion of collagen antibody induced arthritis (CAIA) using four monoclonal antibodies specific for the major epitopes recognized in both collagen induced arthritis and rheumatoid arthritis.
    Nandakumar KS; Holmdahl R
    J Immunol Methods; 2005 Sep; 304(1-2):126-36. PubMed ID: 16125192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tumor necrosis factor receptor loop peptide mimic inhibits bone destruction to the same extent as anti-tumor necrosis factor monoclonal antibody in murine collagen-induced arthritis.
    Saito H; Kojima T; Takahashi M; Horne WC; Baron R; Amagasa T; Ohya K; Aoki K
    Arthritis Rheum; 2007 Apr; 56(4):1164-74. PubMed ID: 17393436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of moxibustion on collagen-induced arthritis in mice.
    Fang JQ; Aoki E; Seto A; Yu Y; Kasahara T; Hisamitsu T
    In Vivo; 1998; 12(4):421-6. PubMed ID: 9706494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric administration of recombinant 65 kDa heat shock protein delays the severity of type II collagen induced arthritis in mice.
    Jorgensen C; Gedon E; Jaquet C; Sany J
    J Rheumatol; 1998 Apr; 25(4):763-7. PubMed ID: 9558182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 reduces the severity of collagen-induced arthritis.
    Tanaka K; Horikawa T; Suzuki S; Kitaura K; Watanabe J; Gotoh A; Shiobara N; Itoh T; Yamane S; Suzuki R; Fukui N; Ochi T
    J Rheumatol; 2008 Dec; 35(12):2316-24. PubMed ID: 19004048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arthritis in mice that are deficient in interleukin-1 receptor antagonist is dependent on genetic background.
    Zhou F; He X; Iwakura Y; Horai R; Stuart JM
    Arthritis Rheum; 2005 Dec; 52(12):3731-8. PubMed ID: 16320323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium.
    Silverman MD; Haas CS; Rad AM; Arbab AS; Koch AE
    Arthritis Rheum; 2007 Jun; 56(6):1817-26. PubMed ID: 17530710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arthritogenic antibodies specific for a major type II collagen triple-helical epitope bind and destabilize cartilage independent of inflammation.
    Nandakumar KS; Bajtner E; Hill L; Böhm B; Rowley MJ; Burkhardt H; Holmdahl R
    Arthritis Rheum; 2008 Jan; 58(1):184-96. PubMed ID: 18163493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.